Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | PREP | P48147 | 2/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BUB1 | O43683 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29431708 | 0.84 | USP2 (0.38) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL30277219 | 0.80 | CHRM2 (0.44) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL28484797 | 0.79 | KDM1A (0.39) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL22214267 | 0.79 | KDM1A (0.39) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL25176823 | 0.79 | KDM1A (0.39) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL16414603 | 0.78 | NR1H2 (0.40) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL16414303 | 0.77 | BUB1 (0.39) | CHRM2CHRM1CHRM3HPGDKDM1A | |
| SCHEMBL22313086 | 0.76 | KDM1A (0.35) | CHRM2CHRM1CHRM3HPGDEPHX2 | |
| SCHEMBL16419900 | 0.76 | BUB1 (0.35) | CHRM2CHRM1CHRM3HPGDKDM1A | |
| SCHEMBL16468545 | 0.75 | CTSK (0.42) | CHRM2CHRM1CHRM3HPGDEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150031887-A1 | 9-AZANORADAMANTANE N-OXYL COMPOUND AND METHOD FOR PRODUCING SAME, AND ORGANIC OXIDATION CATALYST AND METHOD FOR OXIDIZING ALCOHOLS USING 9-AZANORADAMANTANE N-OXYL COMPOUND | TOHOKU UNIVERSITY (JP) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031887-A1 | 9-AZANORADAMANTANE N-OXYL COMPOUND AND METHOD FOR PRODUCING SAME, AND ORGANIC OXIDATION CATALYST AND METHOD FOR OXIDIZING ALCOHOLS USING 9-AZANORADAMANTANE N-OXYL COMPOUND | TET2, FTO, NOX4 | CHRM2 241/4885CHRM1 70/4885CHRM3 489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.